Artgen PJSC (ABIO)

Currency in RUB
44.54
+0.26(+0.59%)
Real-time Data·
ABIO is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
44.0844.86
52 wk Range
31.6272.82
Key Statistics
Prev. Close
44.28
Open
44.48
Day's Range
44.08-44.86
52 wk Range
31.62-72.82
Volume
9.32K
Average Volume (3m)
450.99K
1-Year Change
-32.1037%
Book Value / Share
5.53
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ABIO Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high EBIT valuation multiple

Artgen PJSC News & Analysis

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Earnings

Latest Release
Aug 28, 2026
EPS / Forecast
0.25 / --
Revenue / Forecast
879.16M / --
EPS Revisions
Last 90 days

ABIO Income Statement

Compare ABIO to Peers and Sector

Metrics to compare
ABIO
Peers
Sector
Relationship
P/E Ratio
8,351.5x0.0x−0.3x
PEG Ratio
−83.68−0.080.00
Price/Book
10.8x2.2x2.6x
Price / LTM Sales
2.5x2.9x3.0x
Upside (Analyst Target)
-1,106.1%58.6%
Fair Value Upside
Unlock13.8%8.4%Unlock

Artgen Biotech PJSC, a biotech company, engages in the development of healthcare products in Russia. It develops Betuvax-CoV-2, a vaccine for SARS-COV-2; Tetraflubet, a Flu vaccination; Combi 5V, a Flu + COVID-19 booster vaccine; Betusphere for Immunomodulator; RBT-402, a HPV vaccine; and RBT-501, a vaccine for natural allergy. The company also offers Histograft, a Gene-activated material used as an osteoplastic material, as well as biobanking, genetic research, and regenerative medicine services. In addition, it develops various medical products, such as Xeno-Bone for bone grafting in open operations; Inject-Bone for minimally invasive bone grafting; Inject-Soft use for damage to the skin and mucous membranes; 3D-Bone use for replacement od volumetric bone defects; Cover Bone for guided bone regeneration; and Supl-Bone for bone grafting. The company was formerly known as Public Joint-Stock Company "Human Stem Cells Institute". The company was founded in 2003 and is based in Moscow, Russia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
20.59M27.86%1.23B
Public Companies & Retail Investors
53.31M72.14%3.17B
Total
73.9M100.00%4.4B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
MirMam OOO17.70%13,081,538778,875
International Medical Center of Biomaterials Processing and Cryostorage Public Joint-stock company10.15%7,504,282446,805

People Also Watch

39.34
RTKM
+0.03%
140.00
SPBE
-0.28%
252.80
BELU
+0.96%
231.20
SMLT
+0.26%
2.3610
IRAO
+0.60%

FAQ

What Is the Artgen (ABIO) Stock Price Today?

The Artgen stock price today is 44.54 RUB.

What Stock Exchange Does Artgen Trade On?

Artgen is listed and trades on the Moscow Stock Exchange.

What Is the Stock Symbol for Artgen?

The stock symbol for Artgen is "ABIO."

What Is the Artgen Market Cap?

As of today, Artgen market cap is 3.29B RUB.

What Is Artgen's Earnings Per Share (TTM)?

The Artgen EPS (TTM) is 0.01.

From a Technical Analysis Perspective, Is ABIO a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Artgen Stock Split?

Artgen has split 0 times.

What is the current trading status of Artgen (ABIO)?

As of Oct 03, 2026, Artgen (ABIO) is trading at a price of 44.54 RUB, with a previous close of 44.28 RUB. The stock has fluctuated within a day range of 44.08 RUB to 44.86 RUB, while its 52-week range spans from 31.62 RUB to 72.82 RUB.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.